Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

28.7K
Overview
28.7K
Allergic Reactions02:06

Allergic Reactions

26.3K
Overview
26.3K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Hypersensitivities01:30

Hypersensitivities

7.2K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.2K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

278
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
278

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Common Congenital Anomalies.

Pediatric annals·2025
Same author

The Triad of COVID-19 in Children: Acute COVID-19, Multisystem Inflammatory Syndrome, and Long COVID-Part II.

Pediatric annals·2025
Same author

The Triad of COVID-19 in Children: Acute COVID-19, Multisystem Inflammatory Syndrome, and Long COVID-Part I.

Pediatric annals·2024
Same author

A Meta-analysis of the Utility of Red Cell Distribution Width as a Biomarker to Predict Outcomes in Pediatric Illness (PROSPERO CRD42020208777).

Journal of pediatric intensive care·2024
Same author

Selected Topics in Pediatric Hospital Medicine.

Pediatric annals·2024
Same author

All That Wheezes Is Not Asthma.

Pediatric annals·2024

Related Experiment Video

Updated: Apr 28, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

11.3K

Peanut allergy.

Milind Pansare1, Deepak Kamat

  • 1Division of Allergy/Immunology, Wayne State University, and Pediatric Residency Program, The Carman and Ann Adams Department of Pediatrics, Children's Hospital of Michigan, Detroit, Michigan 48201, USA. mpansare@dmc.org

Current Opinion in Pediatrics
|August 5, 2010
PubMed
Summary
This summary is machine-generated.

Peanut allergy management is advancing, with oral immunotherapy showing promise for desensitization. Research also explores early introduction of peanut protein to build tolerance in infants.

More Related Videos

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.9K
Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus
10:24

Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus

Published on: April 19, 2024

1.7K

Related Experiment Videos

Last Updated: Apr 28, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

11.3K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.9K
Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus
10:24

Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus

Published on: April 19, 2024

1.7K

Area of Science:

  • Allergy and Immunology
  • Pediatric Medicine
  • Clinical Research

Background:

  • Peanut allergy is increasingly prevalent in children, particularly in developed nations.
  • The exact causes for the rising prevalence remain under investigation, with various environmental and specific factors hypothesized.
  • Current management focuses on strict peanut avoidance and emergency treatment for anaphylaxis.

Purpose of the Study:

  • To review and highlight recent breakthroughs in the clinical management of peanut allergy.
  • To discuss emerging diagnostic tools and therapeutic strategies for peanut allergy.

Main Methods:

  • Review of recent clinical trials and prospective studies on peanut allergy management.
  • Analysis of data from studies investigating peanut oral immunotherapy (OIT).
  • Examination of research on early dietary interventions, such as the LEAP study.

Main Results:

  • Peanut oral immunotherapy (OIT) trials have demonstrated successful desensitization in participants.
  • Ongoing studies are evaluating the impact of early high-dose peanut protein introduction versus avoidance in high-risk infants.
  • Component-resolved diagnostics are being developed to better assess clinical sensitivity.

Conclusions:

  • Currently, there is no definitive cure for peanut allergy.
  • Peanut oral immunotherapy presents a viable therapeutic option for achieving desensitization.
  • Further research into immunotherapeutic approaches is underway in both human and animal models.